Antisoma: ATTRACT-1 phase III trial of ASA404 halted following interim analysis
30-Mar-2010
- United Kingdom
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Deutsche Gesellschaft für Sozialmedizin und Prävention e. V. - München, Germany
Go to page
Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine
Go to page
Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively
Go to page
Senexis and Biofocus collaborate to select development candidates for Senexis' Alzheimer's Disease targets
Go to page
Signs & symbols
Go to page